• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Pharmaceuticals Excipients Market, Global Research Reports 2020-2021

report cover
  • 20 May 2020
  • Healthcare
  • 97 Pages
  • Report Code: 24LS-2856
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Pharmaceuticals Excipients Market Reports -MARKET ADVISORY SERVICES

This report covers market size and forecasts of Pharmaceuticals Excipients, including the following market information:
Global Pharmaceuticals Excipients Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Pharmaceuticals Excipients Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Pharmaceuticals Excipients Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Pharmaceuticals Excipients Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players
Major competitors identified in this market include DowDuPont, ER-KANG, JRS Pharma, BASF, Lubrizol, Ashland, Roquette, Shin-Etsu, Evonik, Associated British Foods, Anhui Sunhere Pharmaceutical, CHASE SUN, Shenzhou Yiqiao, EHUA, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Binder
Glidents
Diluents
Disintegrants
Other

Based on the Application:
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Pharmaceuticals Excipients Industry
1.7 COVID-19 Impact: Pharmaceuticals Excipients Market Trends

2 Global Pharmaceuticals Excipients Quarterly Market Size Analysis
2.1 Pharmaceuticals Excipients Business Impact Assessment - COVID-19
2.1.1 Global Pharmaceuticals Excipients Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Pharmaceuticals Excipients Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Pharmaceuticals Excipients Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 Global Pharmaceuticals Excipients Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Pharmaceuticals Excipients Factory Price by Manufacturers
3.3 Location of Key Manufacturers Pharmaceuticals Excipients Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Pharmaceuticals Excipients Market
3.5 Key Manufacturers Pharmaceuticals Excipients Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Pharmaceuticals Excipients Segments, By Type
4.1 Introduction
1.4.1 Binder
1.4.2 Glidents
1.4.3 Diluents
1.4.4 Disintegrants
1.4.5 Other
4.2 By Type, Global Pharmaceuticals Excipients Market Size, 2019-2021
4.2.1 By Type, Global Pharmaceuticals Excipients Market Size by Type, 2020-2021
4.2.2 By Type, Global Pharmaceuticals Excipients Price, 2020-2021

5 Impact of Covid-19 on Pharmaceuticals Excipients Segments, By Application
5.1 Overview
5.5.1 Oral Formulations
5.5.2 Topical Formulations
5.5.3 Parenteral Formulations
5.5.4 Other
5.2 By Application, Global Pharmaceuticals Excipients Market Size, 2019-2021
5.2.1 By Application, Global Pharmaceuticals Excipients Market Size by Application, 2019-2021
5.2.2 By Application, Global Pharmaceuticals Excipients Price, 2020-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 DowDuPont
7.1.1 DowDuPont Business Overview
7.1.2 DowDuPont Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.1.3 DowDuPont Pharmaceuticals Excipients Product Introduction
7.1.4 DowDuPont Response to COVID-19 and Related Developments
7.2 ER-KANG
7.2.1 ER-KANG Business Overview
7.2.2 ER-KANG Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.2.3 ER-KANG Pharmaceuticals Excipients Product Introduction
7.2.4 ER-KANG Response to COVID-19 and Related Developments
7.3 JRS Pharma
7.3.1 JRS Pharma Business Overview
7.3.2 JRS Pharma Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.3.3 JRS Pharma Pharmaceuticals Excipients Product Introduction
7.3.4 JRS Pharma Response to COVID-19 and Related Developments
7.4 BASF
7.4.1 BASF Business Overview
7.4.2 BASF Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.4.3 BASF Pharmaceuticals Excipients Product Introduction
7.4.4 BASF Response to COVID-19 and Related Developments
7.5 Lubrizol
7.5.1 Lubrizol Business Overview
7.5.2 Lubrizol Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.5.3 Lubrizol Pharmaceuticals Excipients Product Introduction
7.5.4 Lubrizol Response to COVID-19 and Related Developments
7.6 Ashland
7.6.1 Ashland Business Overview
7.6.2 Ashland Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.6.3 Ashland Pharmaceuticals Excipients Product Introduction
7.6.4 Ashland Response to COVID-19 and Related Developments
7.7 Roquette
7.7.1 Roquette Business Overview
7.7.2 Roquette Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.7.3 Roquette Pharmaceuticals Excipients Product Introduction
7.7.4 Roquette Response to COVID-19 and Related Developments
7.8 Shin-Etsu
7.8.1 Shin-Etsu Business Overview
7.8.2 Shin-Etsu Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.8.3 Shin-Etsu Pharmaceuticals Excipients Product Introduction
7.8.4 Shin-Etsu Response to COVID-19 and Related Developments
7.9 Evonik
7.9.1 Evonik Business Overview
7.9.2 Evonik Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.9.3 Evonik Pharmaceuticals Excipients Product Introduction
7.9.4 Evonik Response to COVID-19 and Related Developments
7.10 Associated British Foods
7.10.1 Associated British Foods Business Overview
7.10.2 Associated British Foods Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.10.3 Associated British Foods Pharmaceuticals Excipients Product Introduction
7.10.4 Associated British Foods Response to COVID-19 and Related Developments
7.11 Anhui Sunhere Pharmaceutical
7.11.1 Anhui Sunhere Pharmaceutical Business Overview
7.11.2 Anhui Sunhere Pharmaceutical Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.11.3 Anhui Sunhere Pharmaceutical Pharmaceuticals Excipients Product Introduction
7.11.4 Anhui Sunhere Pharmaceutical Response to COVID-19 and Related Developments
7.12 CHASE SUN
7.12.1 CHASE SUN Business Overview
7.12.2 CHASE SUN Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.12.3 CHASE SUN Pharmaceuticals Excipients Product Introduction
7.12.4 CHASE SUN Response to COVID-19 and Related Developments
7.13 Shenzhou Yiqiao
7.13.1 Shenzhou Yiqiao Business Overview
7.13.2 Shenzhou Yiqiao Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.13.3 Shenzhou Yiqiao Pharmaceuticals Excipients Product Introduction
7.13.4 Shenzhou Yiqiao Response to COVID-19 and Related Developments
7.14 EHUA
7.14.1 EHUA Business Overview
7.14.2 EHUA Pharmaceuticals Excipients Quarterly Production and Revenue, 2020
7.14.3 EHUA Pharmaceuticals Excipients Product Introduction
7.14.4 EHUA Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
8.1 Pharmaceuticals Excipients Supply Chain Analysis
8.1.1 Pharmaceuticals Excipients Supply Chain Analysis
8.1.2 Covid-19 Impact on Pharmaceuticals Excipients Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Pharmaceuticals Excipients Distribution Channels
8.2.2 Covid-19 Impact on Pharmaceuticals Excipients Distribution Channels
8.2.3 Pharmaceuticals Excipients Distributors
8.3 Pharmaceuticals Excipients Customers

9 Key Findings

10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Pharmaceuticals Excipients Assessment

Table 9. COVID-19 Impact: Pharmaceuticals Excipients Market Trends

Table 10. COVID-19 Impact Global Pharmaceuticals Excipients Market Size

Table 11. Global Pharmaceuticals Excipients Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Pharmaceuticals Excipients Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Pharmaceuticals Excipients Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Pharmaceuticals Excipients Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Pharmaceuticals Excipients Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Pharmaceuticals Excipients Market Growth Drivers

Table 17. Global Pharmaceuticals Excipients Market Restraints

Table 18. Global Pharmaceuticals Excipients Market Opportunities

Table 19. Global Pharmaceuticals Excipients Market Challenges

Table 20. Key Manufacturers Pharmaceuticals Excipients Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Pharmaceuticals Excipients Market Size, 2019 (K MT) & (US$ Million)

Table 22. Pharmaceuticals Excipients Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Pharmaceuticals Excipients Manufacturing Plants

Table 24. Key Manufacturers Pharmaceuticals Excipients Market Served

Table 25. Date of Key Manufacturers Enter into Pharmaceuticals Excipients Market

Table 26. Key Manufacturers Pharmaceuticals Excipients Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pharmaceuticals Excipients Market Size by Type, 2020, (US$ Million)

Table 29. Global Pharmaceuticals Excipients Market Size by Type, 2020 (K MT)

Table 30. Global Pharmaceuticals Excipients Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Pharmaceuticals Excipients Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Pharmaceuticals Excipients Market Size by Application, 2020-2021 (K MT)

Table 33. Global Pharmaceuticals Excipients Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Pharmaceuticals Excipients Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Pharmaceuticals Excipients Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Pharmaceuticals Excipients Market Size, 2019-2021 (K MT)

Table 38. US Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Pharmaceuticals Excipients Market Size, 2019-2021 (K MT)

Table 43. Germany Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Pharmaceuticals Excipients Market Size, 2019-2021 (K MT)

Table 50. China Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Pharmaceuticals Excipients Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. DowDuPont Business Overview

Table 58. DowDuPont Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. DowDuPont Pharmaceuticals Excipients Product

Table 60. DowDuPont Response to COVID-19 and Related Developments

Table 61. ER-KANG Business Overview

Table 62. ER-KANG Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. ER-KANG Pharmaceuticals Excipients Product

Table 64. ER-KANG Response to COVID-19 and Related Developments

Table 65. JRS Pharma Business Overview

Table 66. JRS Pharma Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. JRS Pharma Pharmaceuticals Excipients Product

Table 68. JRS Pharma Response to COVID-19 and Related Developments

Table 69. BASF Business Overview

Table 70. BASF Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. BASF Pharmaceuticals Excipients Product

Table 72. BASF Response to COVID-19 and Related Developments

Table 73. Lubrizol Business Overview

Table 74. Lubrizol Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Lubrizol Pharmaceuticals Excipients Product

Table 76. Lubrizol Response to COVID-19 and Related Developments

Table 77. Ashland Business Overview

Table 78. Ashland Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Ashland Pharmaceuticals Excipients Product

Table 80. Ashland Response to COVID-19 and Related Developments

Table 81. Roquette Business Overview

Table 82. Roquette Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Roquette Pharmaceuticals Excipients Product

Table 84. Roquette Response to COVID-19 and Related Developments

Table 85. Shin-Etsu Business Overview

Table 86. Shin-Etsu Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Shin-Etsu Pharmaceuticals Excipients Product

Table 88. Shin-Etsu Response to COVID-19 and Related Developments

Table 89. Evonik Business Overview

Table 90. Evonik Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Evonik Pharmaceuticals Excipients Product

Table 92. Evonik Response to COVID-19 and Related Developments

Table 93. Associated British Foods Business Overview

Table 94. Associated British Foods Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Associated British Foods Pharmaceuticals Excipients Product

Table 96. Associated British Foods Response to COVID-19 and Related Developments

Table 97. Anhui Sunhere Pharmaceutical Business Overview

Table 98. Anhui Sunhere Pharmaceutical Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Anhui Sunhere Pharmaceutical Pharmaceuticals Excipients Product

Table 100. Anhui Sunhere Pharmaceutical Response to COVID-19 and Related Developments

Table 101. CHASE SUN Business Overview

Table 102. CHASE SUN Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. CHASE SUN Pharmaceuticals Excipients Product

Table 104. CHASE SUN Response to COVID-19 and Related Developments

Table 105. Shenzhou Yiqiao Business Overview

Table 106. Shenzhou Yiqiao Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Shenzhou Yiqiao Pharmaceuticals Excipients Product

Table 108. Shenzhou Yiqiao Response to COVID-19 and Related Developments

Table 109. EHUA Business Overview

Table 110. EHUA Pharmaceuticals Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. EHUA Pharmaceuticals Excipients Product

Table 112. EHUA Response to COVID-19 and Related Developments

Table 113. Pharmaceuticals Excipients Distributors List

Table 114. Pharmaceuticals Excipients Customers List

Table 115. Covid-19 Impact on Pharmaceuticals Excipients Customers

List of Figures

Figure 1. Pharmaceuticals Excipients Product Picture

Figure 2. Pharmaceuticals Excipients Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Pharmaceuticals Excipients Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Pharmaceuticals Excipients Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Pharmaceuticals Excipients Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Pharmaceuticals Excipients Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Pharmaceuticals Excipients Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Pharmaceuticals Excipients Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Pharmaceuticals Excipients Market Size Market Share, 2019-2021

DowDuPont

ER-KANG

JRS Pharma

BASF

Lubrizol

Ashland

Roquette

Shin-Etsu

Evonik

Associated British Foods

Anhui Sunhere Pharmaceutical

CHASE SUN

Shenzhou Yiqiao

EHUA

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2730

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase